Full-Life Technologies, a Belgium-based, fully integrated global radiotherapeutics company, announced on Sunday that it has named Ted Myles as its new director.

Myles is to also serve as chairman of the audit committee and as a member of the board's compensation committee.

Myles is a biotechnology executive with three decades of financial and operational experience in biotechnology and pharmaceuticals. Presently, he is the chief operating officer and chief financial officer of Scholar Rock. He has served as the COO & CFO of AMAG Pharmaceuticals and COO & CFO of Ocata Therapeutics. He has served as investment banker in SG Cowen Securities' healthcare group.